Express Pharma

GSK announces US FDA approval of Priorix for preventing Measles, Mumps and Rubella

Priorix is currently licensed in over 100 countries worldwide, including all European countries, Canada, Australia and New Zealand, with more than 800 million doses distributed to date

0 214